Search results

Order by most recent / most popular / relevance

Results: 1-9 of 9

Law enforcement in the health care industry: what do new cases against Novartis tell us?

Morvillo Abramowitz Grand Iason & Anello PC
-
USA
-
May 9 2013

In recent years, pharmaceutical companies have faced criminal investigations and charges in regard to alleged off-label marketing of prescription

The 'civil-izing' of white-collar criminal enforcement

Morvillo Abramowitz Grand Iason & Anello PC
-
USA
-
May 7 2013

In recent congressional testimony, Attorney General Eric Holder made waves by acknowledging that "it becomes difficult for the Department of

The Cahill prosecution in Massachusetts: vagueness is still a problem after skilling

Morvillo Abramowitz Grand Iason & Anello PC
-
USA
-
April 4 2013

Vagueness is a common problem in white-collar criminal cases. In many instances the line between legal and illegal conduct is blurry at best. This

Why so few individuals? Government's prosecution of corporate misconduct

Morvillo Abramowitz Grand Iason & Anello PC
-
USA
-
March 5 2013

A company pleads guilty or settles civil charges and makes a large payment to the government. The government condemns the egregious corporate

The nomination of Mary Jo White: more than just politics

Morvillo Abramowitz Grand Iason & Anello PC
-
USA
-
February 20 2013

The President's nomination of Mary Jo White to become Chairman of the SEC has generated reservations as well as praise. Naysayers wonder whether her

Does misdemeanor misbranding survive Caronia?

Morvillo Abramowitz Grand Iason & Anello PC
-
USA
-
December 11 2012

The Court of Appeals for the Second Circuit sent shockwaves through the pharmaceutical industry with its decision in United States v. Caronia. Alfred Caronia was a pharmaceutical sales representative convicted of a misdemeanor conspiracy to introduce a misbranded drug

Analyizing selective waiver of privilege under New York law

Morvillo Abramowitz Grand Iason & Anello PC
-
USA
-
October 9 2012

During government investigations, companies must often decide whether to disclose privileged communications and attorney work product

Can internal investigations be kept from shareholders?

Morvillo Abramowitz Grand Iason & Anello PC
-
USA
-
April 25 2012

Senior management often face sensitive issues, such as allegations of misconduct by executives or improper relationships with vendors

Be careful what you wish for: how deferred and non-prosecution agreements can be used in civil litigation

Morvillo Abramowitz Grand Iason & Anello PC
-
USA
-
January 31 2012

A company under criminal investigation by federal prosecutors often seeks to resolve the investigation by entering into a deferred prosecution agreement (DPA) or non-prosecution agreement (NPA